Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
35,073,865
-
Share change
-
+35,073,365
-
Total reported value
-
$1,657,230,008
-
Price per share
-
$48.08
-
Number of holders
-
56
-
Value change
-
+$1,657,206,010
-
Number of buys
-
55
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2020
As of 31 Dec 2020,
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,073,865 shares.
The largest 10 holders included
BVF INC/IL, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, VR Adviser, LLC, CITADEL ADVISORS LLC, Vivo Capital, LLC, and Avoro Capital Advisors LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.